July 16, 2025 - 00:46

In a significant move for the organization, Aledade has officially announced the appointment of Dr. Lalith Vadlamannati as its new Chief Technology Officer. Dr. Vadlamannati brings a wealth of experience and expertise to the role, having previously held various leadership positions in technology and healthcare innovation.
As Aledade continues to expand its network of independent primary care practices, Dr. Vadlamannati's role will be crucial in advancing the company's technological initiatives. His background in data analytics and software development is expected to enhance Aledade's capabilities in delivering high-quality care and improving patient outcomes.
The company emphasizes its commitment to leveraging technology to empower primary care providers, making healthcare more accessible and efficient. Dr. Vadlamannati's vision aligns with Aledade's mission to support independent practices in navigating the complexities of the healthcare landscape. His leadership is anticipated to drive innovative solutions that will benefit both providers and patients alike.
June 7, 2026 - 04:47
Analyst See More Upside Despite Micron Technology’s (MU) 90% Gains in MayDespite Micron Technology already delivering a stunning 90% gain for investors in May 2026, Wall Street analysts are not backing off. Instead, they are raising their price targets, signaling that...
June 6, 2026 - 04:34
AI Takes Center Stage in 2026 Global Tech Leadership StudyTechnology leaders are shifting their focus dramatically, with artificial intelligence becoming the central pillar of their strategic planning. According to the 2026 Global Technology Leadership...
June 5, 2026 - 04:34
Grass Valley’s Ben Dolinky on Offering Teachable Technology to College Students Across the CountryCollegiate sports production programs face a unique challenge. They must deliver polished, broadcast-ready shows for major networks like ESPN, but their primary mission is education. Ben Dolinky, a...
June 4, 2026 - 11:45
Jeremy Grantham: Distinguishing Great Technology From Great InvestmentsFew investors have spent as much time studying market bubbles as Jeremy Grantham. Over the course of his career, the GMO co-founder correctly identified some of the most significant speculative...